YU48070B - Postupak za dobijanje enol estara i etara 3-acil-2-oksindol-1-karboksamida - Google Patents
Postupak za dobijanje enol estara i etara 3-acil-2-oksindol-1-karboksamidaInfo
- Publication number
- YU48070B YU48070B YU200589A YU200589A YU48070B YU 48070 B YU48070 B YU 48070B YU 200589 A YU200589 A YU 200589A YU 200589 A YU200589 A YU 200589A YU 48070 B YU48070 B YU 48070B
- Authority
- YU
- Yugoslavia
- Prior art keywords
- carbon atoms
- alkyl
- acyl
- group
- etars
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 11
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- -1 chlorobenzoyl Chemical group 0.000 abstract 3
- 125000001589 carboacyl group Chemical group 0.000 abstract 2
- BHMLFPOTZYRDKA-IRXDYDNUSA-N (2s)-2-[(s)-(2-iodophenoxy)-phenylmethyl]morpholine Chemical compound IC1=CC=CC=C1O[C@@H](C=1C=CC=CC=1)[C@H]1OCCNC1 BHMLFPOTZYRDKA-IRXDYDNUSA-N 0.000 abstract 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 abstract 1
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000004423 acyloxy group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 abstract 1
- 229940100198 alkylating agent Drugs 0.000 abstract 1
- 239000002168 alkylating agent Substances 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- FZFAMSAMCHXGEF-UHFFFAOYSA-N chloro formate Chemical compound ClOC=O FZFAMSAMCHXGEF-UHFFFAOYSA-N 0.000 abstract 1
- 125000001309 chloro group Chemical group Cl* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000006254 cycloalkyl carbonyl group Chemical group 0.000 abstract 1
- 230000001419 dependent effect Effects 0.000 abstract 1
- 125000001153 fluoro group Chemical group F* 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 1
- 125000006678 phenoxycarbonyl group Chemical group 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 abstract 1
- 150000003512 tertiary amines Chemical class 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical class O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
POSTUPAK ZA DOBIJANJE ENOL ESTARA I ETARA 3-ACIL-2-OKSINDOL-1-KARBOKSAMIDA formule (I) u kojoj X i Y su svaki odabran iz grupe koju sačinjavaju vodonik, fluoro i hloro; R1 je odabrano iz grupe koju sačin-javaju 2-tienil i benzil; i R je odabrano iz grupe koju sačinjavaju alkanoil koji ima dva do deset ugljenikovih atoma, cik-loalkilkarbonil koji ima pet do sedam ugljenikovih atoma, fenilalkanoil koji ima sedam do deset ugljenikovih atoma, hlorobenzoil, metoksibenzoil, tenoil, omega-alkok-sikrbonilalkanoil, pri čemu alkoksi ima jedan do triugljenikova atoma, i pomenuti alkanoil ima tri do pet ugljenikovih atoma, alkoksikarbonil ima dva do deset ugljenikovih atoma, fenok-sikarbonil, 1-(aciloksi)alkil, pri čemu acil ima dva do četiri ugljenikova atoma i pomenuti alkil ima jedan do četiri ugljenikova atoma, alkil sa jedan do tri atoma ugljenika, alkil-sulfonil koji ima jedan do tri ugljenikova atoma, metilfenilsul-fonil i dialkilsulfonat, pri čemu pomenuti alkil svaki ima od jedan do tri ugljenikova atoma, naznačen time, što obuhvata reakciju jedinjenja formule sa ekvimolarnom količinom ili blagim viškom potrebnog hlorida kiseline hloroformijata, oksonijum soli ili sredstva za alkilovanje u reakciono inertnom rastvaraču koji sadrži ek-vimolarnu količinu tercijarnog amina, na oko 0В°C. Sve do u suštini završetka reakcije. Prijava sadrži još 1 nezavisan i 2 zavisna zahteva.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US1988/003658 WO1990004393A1 (en) | 1988-10-18 | 1988-10-18 | Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| YU200589A YU200589A (en) | 1991-02-28 |
| YU48070B true YU48070B (sh) | 1997-01-08 |
Family
ID=22208957
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| YU200589A YU48070B (sh) | 1988-10-18 | 1989-10-16 | Postupak za dobijanje enol estara i etara 3-acil-2-oksindol-1-karboksamida |
Country Status (33)
| Country | Link |
|---|---|
| US (1) | US5118703A (sh) |
| JP (1) | JPH07597B2 (sh) |
| KR (1) | KR910007237B1 (sh) |
| CN (1) | CN1022241C (sh) |
| AP (1) | AP118A (sh) |
| AR (1) | AR246519A1 (sh) |
| AT (1) | ATE125794T1 (sh) |
| AU (1) | AU606819B2 (sh) |
| BG (1) | BG50834A3 (sh) |
| CA (1) | CA1339558C (sh) |
| CZ (1) | CZ278983B6 (sh) |
| DD (1) | DD285604A5 (sh) |
| DK (1) | DK514989A (sh) |
| EG (1) | EG19887A (sh) |
| FI (1) | FI95253C (sh) |
| HU (1) | HU208421B (sh) |
| IE (1) | IE66586B1 (sh) |
| IL (1) | IL91960A (sh) |
| IS (1) | IS1598B (sh) |
| MA (1) | MA21657A1 (sh) |
| MX (1) | MX18021A (sh) |
| MY (1) | MY104238A (sh) |
| NO (1) | NO178027C (sh) |
| NZ (1) | NZ231044A (sh) |
| OA (1) | OA09140A (sh) |
| PH (1) | PH27554A (sh) |
| PL (2) | PL162316B1 (sh) |
| PT (1) | PT92000B (sh) |
| RO (1) | RO109195B1 (sh) |
| RU (1) | RU2036905C1 (sh) |
| SK (1) | SK278175B6 (sh) |
| WO (1) | WO1990004393A1 (sh) |
| YU (1) | YU48070B (sh) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5059693A (en) * | 1989-10-06 | 1991-10-22 | Pfizer Inc. | Process for making 3-aroyl-2-oxindole-1-carboxamides |
| US5648502A (en) * | 1992-11-23 | 1997-07-15 | Pfizer Inc. | Regioselective synthesis of 4-chloro-2-thiophenecarboxylic acid |
| US5270331A (en) * | 1993-01-26 | 1993-12-14 | Pfizer, Inc. | Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides |
| WO1994018194A1 (en) * | 1993-02-09 | 1994-08-18 | Pfizer Inc. | Oxindole 1-[n-(alkoxycarbonyl)]carboxamides and 1-(n-carboxamido)carboxamides as intiinflammatory agents |
| US5449788A (en) * | 1994-01-28 | 1995-09-12 | Catalytica, Inc. | Process for preparing 2-oxindole-1-carboxamides |
| CN1094819C (zh) * | 1997-04-30 | 2002-11-27 | 大兴株式会社 | 环状坯料之制造装置 |
| EP0984012A3 (en) * | 1998-08-31 | 2001-01-10 | Pfizer Products Inc. | Nitric oxide releasing oxindole prodrugs with analgesic and anti-inflammatory properties |
| EP1223809A4 (en) * | 1999-10-26 | 2004-03-03 | Univ Texas Southwestern Med Ct | METHODS OF TREATING HAIR LOSS COMPRISING THE ADMINISTRATION OF AN INDOLIN COMPOUND |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL96047C (sh) * | 1956-06-08 | |||
| US3564009A (en) * | 1966-01-13 | 1971-02-16 | Sumitomo Chemical Co | Process for producing 1-acylindole derivatives |
| BE756447A (fr) * | 1969-10-15 | 1971-03-22 | Pfizer | Oxindolecarboxamides |
| US3923996A (en) * | 1972-07-31 | 1975-12-02 | Sandoz Ag | 3-Substituted-oxindoles in compositions and methods of treating obesity |
| IE53102B1 (en) * | 1981-05-12 | 1988-06-22 | Ici Plc | Pharmaceutical spiro-succinimide derivatives |
| DE3268971D1 (en) * | 1981-10-06 | 1986-03-20 | Ici Plc | Biochemical process |
| US4556672A (en) * | 1984-03-19 | 1985-12-03 | Pfizer Inc. | 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents |
| US4752609A (en) * | 1985-06-20 | 1988-06-21 | Pfizer Inc. | Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds |
| US5036099A (en) * | 1987-02-02 | 1991-07-30 | Pfizer Inc. | Anhydrous, crystalline sodium salt of 5-chloro-3-(2-thenoyl)-2-oxindole-1-carboxamide |
| ES2075055T3 (es) * | 1988-10-18 | 1995-10-01 | Pfizer | Profarmacos de 3-acil-2-oxindol-1-carboxamidas antiinflamatorias. |
| US5047554A (en) * | 1989-04-18 | 1991-09-10 | Pfizer Inc. | 3-substituted-2-oxindole derivatives |
| US5059693A (en) * | 1989-10-06 | 1991-10-22 | Pfizer Inc. | Process for making 3-aroyl-2-oxindole-1-carboxamides |
-
1988
- 1988-10-18 US US07/675,883 patent/US5118703A/en not_active Expired - Lifetime
- 1988-10-18 WO PCT/US1988/003658 patent/WO1990004393A1/en active IP Right Grant
- 1988-10-18 RO RO147347A patent/RO109195B1/ro unknown
- 1988-10-18 MX MX1802188A patent/MX18021A/es unknown
- 1988-10-18 HU HU886740A patent/HU208421B/hu not_active IP Right Cessation
- 1988-10-18 SK SK5906-89A patent/SK278175B6/sk unknown
-
1989
- 1989-09-20 IS IS3509A patent/IS1598B/is unknown
- 1989-09-28 CA CA000614317A patent/CA1339558C/en not_active Expired - Fee Related
- 1989-10-04 PH PH39329A patent/PH27554A/en unknown
- 1989-10-09 AT AT89310319T patent/ATE125794T1/de active
- 1989-10-12 IL IL9196089A patent/IL91960A/xx not_active IP Right Cessation
- 1989-10-16 BG BG90022A patent/BG50834A3/xx unknown
- 1989-10-16 PT PT92000A patent/PT92000B/pt not_active IP Right Cessation
- 1989-10-16 YU YU200589A patent/YU48070B/sh unknown
- 1989-10-16 AP APAP/P/1989/000141A patent/AP118A/en active
- 1989-10-16 MY MYPI89001415A patent/MY104238A/en unknown
- 1989-10-17 OA OA59665A patent/OA09140A/xx unknown
- 1989-10-17 AU AU42956/89A patent/AU606819B2/en not_active Ceased
- 1989-10-17 NZ NZ231044A patent/NZ231044A/en unknown
- 1989-10-17 AR AR89315179A patent/AR246519A1/es active
- 1989-10-17 PL PL89281871A patent/PL162316B1/pl unknown
- 1989-10-17 JP JP1270174A patent/JPH07597B2/ja not_active Expired - Lifetime
- 1989-10-17 CN CN89107943A patent/CN1022241C/zh not_active Expired - Fee Related
- 1989-10-17 DD DD89333653A patent/DD285604A5/de not_active IP Right Cessation
- 1989-10-17 DK DK514989A patent/DK514989A/da not_active Application Discontinuation
- 1989-10-17 MA MA21909A patent/MA21657A1/fr unknown
- 1989-10-17 KR KR1019890014914A patent/KR910007237B1/ko not_active IP Right Cessation
- 1989-10-17 PL PL89296831A patent/PL163112B1/pl unknown
- 1989-10-17 IE IE333289A patent/IE66586B1/en not_active IP Right Cessation
- 1989-10-18 EG EG49689A patent/EG19887A/xx active
- 1989-10-18 CZ CS895906A patent/CZ278983B6/cs not_active IP Right Cessation
-
1991
- 1991-04-17 FI FI911855A patent/FI95253C/fi not_active IP Right Cessation
- 1991-04-17 RU SU914895525A patent/RU2036905C1/ru active
- 1991-04-17 NO NO911512A patent/NO178027C/no unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| YU49221B (sh) | Novi derivati eritromicina, postupak za njihovo dobivanje i njihova primena kao lekova | |
| HUP0103357A2 (hu) | Halichondrinanalógok és eljárás előállításukra és alkalmazásukra | |
| UY28040A1 (es) | Antagonistas de cgrp elegidos, procedimiento para su preparación, así como su empleo como medicamentos. | |
| AR028914A1 (es) | 2-guanidino-4-aril-quinazolinas como inhibidores de nhe-3 | |
| SK7895A3 (en) | Hydroxamic acid derivatives as metalloproteinase inhibitors their use for production of pharmaceutical agents and pharmaceutical agents with their contents | |
| AR017164A1 (es) | Derivados de la benzamidina, un procedimiento para prepararlos, el empleo de los mismos para preparar un medicamento, los medicamentos y laspreparaciones farmaceuticas que contienen estos derivados de la benzamidina, y un procedimiento para obtener estas preparaciones farmaceuticas. | |
| YU48070B (sh) | Postupak za dobijanje enol estara i etara 3-acil-2-oksindol-1-karboksamida | |
| FI955438A0 (fi) | N-asyylisulfamidihappoesterit (tai -tioesterit), N-asyylisulfonamidit ja N-sulfonyylikarbamiinihappoesterit (tai -tioesterit) hyperkolesteroleemisina aineina | |
| AR004516A1 (es) | Derivados de pirimidina, su uso, procedimientos para prepararlos y medicamentos que los contienen | |
| HUP0203483A2 (hu) | Purinszármazékok | |
| FR2796276B1 (fr) | Composition sous forme solide comprenant une huile et un compose gelifiant particulier, procede de traitement cosmetique et utilisation dudit compose | |
| ES2011296B3 (es) | Derivados de benzo[b]tiofeno y benzo [b]furano carboxamidas, sus procedimientos de preparacion y los medicamentos que los contienen. | |
| YU73001A (sh) | Derivati karbaminske kiseline i njihova primena kao liganada metabotropnih glutamat receptora | |
| ES2098735T3 (es) | N-acilacion selectiva de amino-alcoholes. | |
| DE60332350D1 (de) | Disazofarbstoffe und sie enthaltende tintenstrahldrucktinten | |
| HUP0002272A2 (hu) | Piperazinszármazékok, eljárás előállításukra, e vegyületeket tartalmazó gyógyászati készítmények és alkalmazásuk | |
| CO4750662A1 (es) | DERIVADOS DE BENZO (g) QUINOLINA | |
| ATE51618T1 (de) | Imidazolderivate, verfahren zu deren herstellung, deren anwendung und pharmazeutische zusammenstellungen. | |
| HUP0003484A2 (hu) | Pirrolidin-3-karbonsav-származékok és alkalmazásuk endotelin antagonistaként | |
| YU62991A (sh) | Karbapenemska jedinjenja | |
| ATE118758T1 (de) | Derivate von endogenen mediatoren, ihre salze, verfahren zur herstellung, anwendungen und zusammensetzungen, die diese enthalten. | |
| DK222385A (da) | 6-oxygeneret-1,3,4,5-tetrahydrobenz-(cd)indol-4-aminer | |
| ES2020508B3 (es) | Derivados citoprotectores utiles para enfermedades isquemicas, su preparacion y composiciones que los contienen. | |
| MX9304467A (es) | Nuevos derivados fosfonados de ariletanolaminas, procedimiento para su preparacion y composiciones farmaceuticas y veterinarias que los contienen. | |
| ES2059468T3 (es) | Derivados imida, su produccion y uso. |